pediatric patient / parent

Update on Alayna: Loving Kindergarten, but Mom still worries

Person's Name:

Ashley and Alayna Numbers

Alayna is doing all the normal activities for a child her age. Learning to read, making many friends, and taking gymnastics are parts of ordinary life for kindergarteners. She’s looking forward to soccer and more sports when pandemic life eases. Few signs remain that she battled

Bone Marrow Disease(s):

Content source:

web exclusive

Transplantation for Older MDS Patients

In this discussion, Dr. Nandita Khera of Associate Professor of Mayo Clinic and Dr. Linda Burns Sr. Scientific Director of CIBMTR discuss which treatments are available to older MDS patients.

Certain Patients With Myelodysplastic Syndromes, Acute Leukemia at Higher Risk of Severe COVID-19 Illness

Clinical Trials in Depth

Clinical trials, also called research studies, may offer good treatment options for some people with

Leslie S. Kean, MD, PhD, on Bone Marrow Transplantation: Using Abatacept to Prevent Graft-vs-Host Disease

Leslie S. Kean, MD, PhD, of Dana-Farber/Boston Children's Cancer and Blood Disorders Center, discusses findings from her analysis of the International Blood and Marrow Transplant Research Database, which led to the recent FDA approval of abatacept for the prevention of acute graft-vs-host disease (GVHD) in adult and pediatric patients. The data suggest improved overall survival with the immunosuppressant abatacept in combination with a calcineurin inhibitor and methotrexate following 7/8 HLA–matched unrelated allogeneic hematopoietic stem cell transplantation (Abstract 3912).

Eunice S. Wang, MD, on FLT3-Mutated AML: Gilteritinib and Azacitidine for Intensive Induction Chemotherapy–Ineligible Patients

Eunice S. Wang, MD, of Roswell Park Comprehensive Cancer Center, discusses phase III results showing that gilteritinib and azacitidine led to significantly higher composite complete response rates in patients with newly diagnosed FLT3-mutant

Aspaveli® (pegcetacoplan) approved in EU as orphan drug for treatment of PNH

Published: Dec 15, 2021

STOCKHOLM, Dec. 15, 2021 /PRNewswire/ --

AML Management: Feel Better With Food and Physical Activity

If you’re receiving treatment for

Parenting a Child with Bone Marrow Failure Disease - Summer 2021 Conference

When a child is diagnosed with a bone marrow failure disease, often the focus is soley on the child's medical care.

Swapna Thota, MD

Thota, Swapna

Assistant Professor of Medicine

University of Tennessee

As a physician caring for patients with acute leukemias and related disorders, I have a sustained focus on translational research in hematologic malignancies. Genomic sequencing technology revolutionized our understanding of cancer biology. My research focuses on exploring the dynamic changes of tumor immune microenvironment with clonal evolution of myeloid malignancies. Targeting inflammaging of

Online Profile:

Assistant Professor